0001209191-19-050362.txt : 20190920 0001209191-19-050362.hdr.sgml : 20190920 20190920171744 ACCESSION NUMBER: 0001209191-19-050362 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190725 FILED AS OF DATE: 20190920 DATE AS OF CHANGE: 20190920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 191105426 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-25 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-07-25 4 P 0 60 5.87 A 13298 D Common Stock 2019-07-26 4 P 0 60 5.86 A 13358 D Common Stock 2019-07-29 4 P 0 60 5.87 A 13418 D Common Stock 2019-07-30 4 P 0 60 5.83 A 13478 D Common Stock 2019-07-31 4 P 0 60 5.94 A 13538 D Common Stock 2019-08-02 4 P 0 120 6.15 A 13658 D Common Stock 2019-08-05 4 P 0 60 6.17 A 13718 D Common Stock 2019-08-07 4 P 0 60 6.07 A 13778 D Common Stock 2019-08-09 4 P 0 120 6.02 A 13898 D Common Stock 2019-08-12 4 P 0 60 5.91 A 13958 D Common Stock 2019-08-13 4 P 0 60 5.78 A 14018 D Common Stock 2019-08-14 4 P 0 60 5.49 A 14078 D Common Stock 2019-08-16 4 P 0 120 5.62 A 14198 D Common Stock 2019-08-19 4 P 0 60 5.51 A 14258 D Common Stock 2019-08-20 4 P 0 60 5.43 A 14318 D Common Stock 2019-08-21 4 P 0 60 5.49 A 14378 D Common Stock 2019-08-22 4 P 0 60 5.31 A 14438 D Common Stock 2019-08-23 4 P 0 60 5.38 A 14498 D Common Stock 2019-08-27 4 P 0 120 5.19 A 14618 D Common Stock 2019-08-29 4 P 0 120 5.04 A 14738 D Common Stock 2019-08-30 4 P 0 60 5.14 A 14798 D Common Stock 2019-09-04 4 P 0 60 4.79 A 14858 D Common Stock 2019-09-06 4 P 0 120 4.91 A 14978 D Common Stock 2019-09-09 4 P 0 60 5.19 A 15038 D Common Stock 2019-09-10 4 P 0 60 5.38 A 15098 D Common Stock 2019-09-11 4 P 0 60 5.02 A 15158 D Common Stock 2019-09-13 4 P 0 120 5.18 A 15278 D Common Stock 2019-09-16 4 P 0 60 4.97 A 15338 D Common Stock 2019-09-18 4 P 0 120 4.93 A 15458 D Common Stock 2019-09-19 4 P 0 60 5.21 A 15518 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Joseph C. Galante by /s/ Michael Bonner as attorney-in-fact 2019-09-20